Home

妖女迷行

Dengue sweeps Sri Lanka_我的网站

花木兰传奇

一 |     Colombo, Oct 14 (UNI) The number of dengue patients has increased by 300 per cent compared to 2021 in Sri Lanka, a newspaper reported on Friday.
The President of the College of Medical Laboratory Science (CMLS), Ravi Kumudesh, told The Island that about 60,000 cases have been reported so far this year across the country.
“During the same time in 2021, fewer than 20,000 cases were reported. Most cases have been reported from the Western Province. Higher numbers are also reported from Kandy, Galle, Jaffna, Kegalle, Puttalam, and Kurunegala districts,” he said.
Kumudesh said 36 health divisions have been declared vulnerable areas. However, most government hospitals did not have testing kits to detect dengue, he said.
“The Ministry of Health has not paid a number of companies for testing kits purchased in the past. Now, these companies do not sell test kits to the Ministry of Health.
"In the meantime, Rs. 125 million earmarked for purchasing medicine in the 2022 third quarter has not been spent. Another $60 million are left in the Indian credit line to buy medicines. We can easily buy testing kits and reagents with this money,” he said.
UNI MR。    8月26日消息,多位博主在社交平台上晒出邀请函,预告天马将于8月26日在厦门举办高端OLED技术品牌发布会,本次活动将正式推出全新一代天工屏。     结合此前爆料的消息来看,这一代天工屏将由OPPO Find X10系列全球首发,这也是行业内综合素质最好的手机屏幕。          OPPO首席产品官刘作虎此前曾介绍过Find X10系列所搭载的天工屏的部分细节。他表示,屏幕好不好,参数只是最后呈现的结果,很多差距其实早在源头就已经拉开。    这一次,OPPO从发光基材定制到像素级校准都做了全面升级,将RGB三色发光材料全部换新。蓝色材料的发光效率更高,红色和绿色则更加纯净,光谱得到了全面优化,并升级至BT.2020色域,实现了目前行业最高的覆盖率,能够更接近真实世界的色彩层次,屏幕也因此更加通透,同时也更加护眼。

二 |     去年Find X9系列上率先搭载的1nit暗光显示,正是明眸护眼屏引领行业的重要体现。好屏幕没有捷径,就是回归本源,把每一处细节做扎实。看过这块屏幕之后,再看其他屏幕,真的回不去了。    
OPPO Find X9系列     值得关注的是,OPPO还在业内打造了首条自研屏幕双产线。一条是定制的高规格屏幕产线,负责从发光材料到模组的硬件制造;另一条是自有显示科学产线,负责出厂前逐屏、逐子像素的精密校准,做到了全链路精准管控。     首发天工屏的OPPO Find X10系列将在9月份正式发布。    

         

     【本文结束】如需转载请务必注明出处:      责任编辑:振亭     文章内容举报     

Current article:http://www.liawucunsainantaonao.sbs/news/20260826_5014134.ppt

Published on:14:45:51


Copyright 妖女迷行 2020-2099 About us | recruitment information | contact us | Site map | Friendly links | Feedback | Site map